Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,000 | 69,000 | 110,000 | 70,330 | 194,850 |
| Marketable Securities | 0 | 5,000 | 4,000 | 5,070 | 5,490 |
| Receivables | 436,000 | 491,000 | 547,000 | 537,780 | 494,050 |
| Inventories | 414,000 | 456,000 | 463,000 | 461,980 | 491,820 |
| Other current assets | 173,000 | 171,000 | 179,000 | 191,460 | 185,970 |
| TOTAL | $1,095,000 | $1,192,000 | $1,303,000 | $1,266,620 | $1,372,180 |
| Non-Current Assets | |||||
| PPE Net | 976,000 | N/A | 931,000 | N/A | 924,470 |
| Investments And Advances | 0 | 0 | 0 | 34,050 | 79,280 |
| Other Non-Current Assets | 1,912,000 | 1,927,000 | 1,925,000 | 1,912,130 | 1,871,830 |
| TOTAL | $2,888,000 | $1,927,000 | $2,856,000 | $1,946,180 | $2,875,580 |
| Total Assets | $3,639,000 | $3,746,000 | $3,876,000 | $3,892,710 | $3,994,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 444,000 | 358,000 | 530,000 | 108,590 | 70,800 |
| Accrued Expenses | 0 | 58,000 | 0 | 316,250 | 425,380 |
| Other current liabilities | 39,000 | 26,000 | 50,000 | 148,500 | 7,520 |
| TOTAL | $1,042,000 | $945,000 | $1,607,000 | $1,619,650 | $2,637,340 |
| Non-Current Liabilities | |||||
| Long Term Debt | 761,000 | 1,060,000 | 1,260,000 | 1,363,820 | 553,870 |
| Other Non-Current Liabilities | 83,000 | 83,000 | 88,000 | 88,090 | 77,740 |
| TOTAL | $844,000 | $1,143,000 | $1,348,000 | $1,451,910 | $631,610 |
| Total Liabilities | $1,886,000 | $2,088,000 | $2,955,000 | $3,071,570 | $3,268,960 |
| Shareholders' Equity | |||||
| Common Shares | 4,000 | 4,000 | 4,000 | 3,940 | 1,960 |
| Retained earnings | 645,000 | 590,000 | 481,000 | 381,240 | 312,750 |
| Other shareholders' equity | -103,000 | -117,000 | -101,000 | -70,800 | -78,090 |
| TOTAL | $1,753,000 | $1,658,000 | $921,000 | $821,130 | $725,040 |
| Total Liabilities And Equity | $3,639,000 | $3,746,000 | $3,876,000 | $3,892,700 | $3,994,000 |